| abstract |
The present invention provides compositions useful for treating cancer. The composition includes a synergistic combination of an antineoplastic thiol-binding mitochondrial oxidant and an anti-neoplastic nucleic acid binding agent, an anti-neoplastic antimetabolite base analog, or docetaxel. Also provided are methods for testing the synergistic effect of the combination, and methods of treating cancer using the synergistic combination. [Selection] Figure 1 |